Invest now
Abbott India share price
Moderate risk
You have to be logged in to add this to Watchlist.- ₹25,570.00(1.18%)September 11, 2026 15:29:16 PM IST
- NSE
- BSE
- Vol : 10.92 K (NSE + BSE)Last 20 day avg : 11.71 K
Abbott India is trading 1.18% upper at Rs 25,570.00 as compared to its last closing price. Abbott India has been trading in the price range of 25,662.90 & 25,140.50. Abbott India has given -11.57% in this year & -1.98% in the last 5 days. Abbott India has TTM P/E ratio 33.33 as compared to the sector P/E of 36.32.There are 7 analysts who have initiated coverage on Abbott India. There are 4 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 428.52 Crores in its last quarter.Listed peers of Abbott India include Sun Pharmaceutical Industries (-1.18%), Divi's Laboratories (-0.84%), Torrent Pharmaceuticals (0.95%).The Mutual Fund holding in Abbott India was at 7.44% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in Abbott India was at 0.38% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 14 Sep 2026, 06:14 PM IST
- BetaLow volatility0.15Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.04The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry2.08Annual dividends as a percentage of the stock price.
- P/BLower than historical values11.24The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values33.24Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates Fair Valuation1.87The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Abbott India News
Abbott India Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,842.00 | -1.18 | 4,41,947.09 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,326.00 | -0.84 | 2,47,576.00 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,975.00 | 0.95 | 1,89,226.24 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,365.00 | -1.09 | 1,10,191.95 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,119.50 | 0.13 | 1,11,670.55 | 21.19 | 4.24 | 0.09 | 14.22 |
Mutual Fund Ownership
View allAbbott India Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-05-11 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
About the company Abbott India
- IndustryBiotechnology & Drugs
- ISININE358A01014
- BSE Code500488
- NSE CodeABBOTINDIA
Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.
Abbott India Share Price FAQs
Abbott India is trading at 25570.00 as on Fri Sep 11 2026 09:59:16. This is 1.18% upper as compared to its previous closing price of 25272.60.
The market capitalization of Abbott India is 54368.68 Cr as on Fri Sep 11 2026 09:59:16.
The average broker rating on Abbott India is Strong Buy. The breakup of analyst rating is given below -
- 4 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 1 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Abbott India is 31505.71 whereas the 52 wk low is 25049.28
Abbott India can be analyzed on the following key metrics -
- TTM P/E: 33.33
- Sector P/E: 36.32
- Dividend Yield: 2.05%
- D/E ratio: -
Abbott India reported a net profit of 1552.02 Cr in 2026.
The Mutual Fund Shareholding was 7.44% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Abbott India QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.